| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Schizophrenia | 69 | 2024 | 6937 | 2.310 |
Why?
|
| Genome-Wide Association Study | 95 | 2021 | 12688 | 2.090 |
Why?
|
| Polymorphism, Single Nucleotide | 115 | 2021 | 15941 | 2.080 |
Why?
|
| Genetic Predisposition to Disease | 107 | 2022 | 17912 | 2.060 |
Why?
|
| Sleep | 29 | 2024 | 4766 | 1.990 |
Why?
|
| DNA Copy Number Variations | 19 | 2019 | 2020 | 1.680 |
Why?
|
| Linkage Disequilibrium | 32 | 2019 | 2005 | 1.300 |
Why?
|
| Bipolar Disorder | 37 | 2021 | 5091 | 1.300 |
Why?
|
| Electroencephalography | 14 | 2024 | 6224 | 1.160 |
Why?
|
| Genetic Variation | 36 | 2021 | 6581 | 1.150 |
Why?
|
| Genome, Human | 25 | 2016 | 4425 | 1.080 |
Why?
|
| Multifactorial Inheritance | 12 | 2018 | 1392 | 0.960 |
Why?
|
| Chromosome Mapping | 26 | 2019 | 4638 | 0.950 |
Why?
|
| Quantitative Trait Loci | 17 | 2022 | 2116 | 0.900 |
Why?
|
| Genetic Linkage | 11 | 2019 | 2382 | 0.900 |
Why?
|
| Models, Genetic | 27 | 2018 | 3446 | 0.850 |
Why?
|
| Gene Frequency | 32 | 2018 | 3647 | 0.820 |
Why?
|
| Twins | 6 | 2020 | 340 | 0.810 |
Why?
|
| Genetic Loci | 15 | 2019 | 2631 | 0.800 |
Why?
|
| Snoring | 1 | 2023 | 209 | 0.790 |
Why?
|
| Haplotypes | 22 | 2014 | 2775 | 0.700 |
Why?
|
| Genotype | 60 | 2021 | 13009 | 0.700 |
Why?
|
| Calcium Channels, L-Type | 8 | 2017 | 242 | 0.680 |
Why?
|
| Case-Control Studies | 63 | 2020 | 22168 | 0.660 |
Why?
|
| Software | 8 | 2015 | 4434 | 0.640 |
Why?
|
| Technology | 1 | 2021 | 292 | 0.630 |
Why?
|
| Genetics, Population | 13 | 2015 | 939 | 0.610 |
Why?
|
| Polysomnography | 12 | 2024 | 1847 | 0.580 |
Why?
|
| Alleles | 34 | 2021 | 6922 | 0.580 |
Why?
|
| Genetics, Behavioral | 4 | 2020 | 53 | 0.530 |
Why?
|
| Quantitative Trait, Heritable | 11 | 2018 | 543 | 0.520 |
Why?
|
| Genetic Markers | 15 | 2017 | 2613 | 0.520 |
Why?
|
| Exons | 7 | 2019 | 2393 | 0.500 |
Why?
|
| Environment | 7 | 2007 | 1122 | 0.470 |
Why?
|
| Phenotype | 32 | 2023 | 16606 | 0.450 |
Why?
|
| Sleep Apnea, Obstructive | 6 | 2023 | 1871 | 0.450 |
Why?
|
| Genetic Diseases, Inborn | 3 | 2014 | 605 | 0.430 |
Why?
|
| Nerve Tissue Proteins | 15 | 2019 | 4414 | 0.430 |
Why?
|
| Twin Studies as Topic | 2 | 2020 | 104 | 0.420 |
Why?
|
| Genetic Phenomena | 1 | 2012 | 6 | 0.420 |
Why?
|
| Humans | 243 | 2024 | 761423 | 0.420 |
Why?
|
| Sequence Analysis, DNA | 7 | 2022 | 4741 | 0.410 |
Why?
|
| Depressive Disorder, Major | 13 | 2019 | 4760 | 0.410 |
Why?
|
| Sleep, REM | 5 | 2022 | 594 | 0.400 |
Why?
|
| Nuclear Family | 4 | 2007 | 313 | 0.390 |
Why?
|
| Social Environment | 4 | 2007 | 1020 | 0.380 |
Why?
|
| Actigraphy | 4 | 2024 | 520 | 0.380 |
Why?
|
| Models, Statistical | 8 | 2011 | 5077 | 0.370 |
Why?
|
| Population | 2 | 2008 | 141 | 0.360 |
Why?
|
| Biostatistics | 1 | 2012 | 164 | 0.360 |
Why?
|
| Epistasis, Genetic | 3 | 2012 | 352 | 0.340 |
Why?
|
| Heterozygote | 3 | 2015 | 2803 | 0.330 |
Why?
|
| Sleep Stages | 5 | 2024 | 694 | 0.330 |
Why?
|
| Life Change Events | 4 | 2016 | 952 | 0.330 |
Why?
|
| Sweden | 11 | 2019 | 1379 | 0.330 |
Why?
|
| Lithium Carbonate | 1 | 2009 | 179 | 0.310 |
Why?
|
| Chromosomes, Human, X | 4 | 2018 | 321 | 0.310 |
Why?
|
| Oxyhemoglobins | 2 | 2019 | 211 | 0.310 |
Why?
|
| Synapses | 6 | 2017 | 1769 | 0.310 |
Why?
|
| Myosin Type V | 1 | 2008 | 33 | 0.300 |
Why?
|
| Sleep Deprivation | 3 | 2024 | 843 | 0.300 |
Why?
|
| Male | 120 | 2024 | 360736 | 0.300 |
Why?
|
| Genetic Association Studies | 8 | 2021 | 2734 | 0.290 |
Why?
|
| Cytoskeletal Proteins | 7 | 2017 | 1342 | 0.290 |
Why?
|
| Intelligence | 4 | 2017 | 924 | 0.290 |
Why?
|
| Mutation | 15 | 2020 | 30045 | 0.280 |
Why?
|
| Child Development Disorders, Pervasive | 5 | 2014 | 600 | 0.280 |
Why?
|
| Cognition Disorders | 6 | 2017 | 3979 | 0.280 |
Why?
|
| Pedigree | 11 | 2014 | 4589 | 0.280 |
Why?
|
| Disease | 2 | 2015 | 672 | 0.280 |
Why?
|
| Female | 125 | 2024 | 392581 | 0.280 |
Why?
|
| Cognition | 5 | 2023 | 6986 | 0.270 |
Why?
|
| Medical History Taking | 2 | 2008 | 773 | 0.270 |
Why?
|
| Biotechnology | 1 | 2008 | 282 | 0.270 |
Why?
|
| Myosin Heavy Chains | 1 | 2008 | 405 | 0.270 |
Why?
|
| Family | 7 | 2015 | 3197 | 0.260 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 3 | 2022 | 1081 | 0.250 |
Why?
|
| GTPase-Activating Proteins | 3 | 2019 | 471 | 0.250 |
Why?
|
| Inheritance Patterns | 5 | 2015 | 341 | 0.240 |
Why?
|
| Brain | 8 | 2023 | 27107 | 0.240 |
Why?
|
| Ankyrins | 4 | 2017 | 123 | 0.240 |
Why?
|
| Stress Disorders, Post-Traumatic | 6 | 2014 | 4579 | 0.240 |
Why?
|
| Genome | 2 | 2011 | 1740 | 0.240 |
Why?
|
| p21-Activated Kinases | 2 | 2016 | 128 | 0.230 |
Why?
|
| Psychotic Disorders | 7 | 2019 | 3223 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 8 | 3 | 2019 | 452 | 0.230 |
Why?
|
| Depressive Disorder | 5 | 2016 | 3728 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 6 | 3 | 2010 | 375 | 0.220 |
Why?
|
| Gene Dosage | 4 | 2019 | 1218 | 0.220 |
Why?
|
| Nuclear Proteins | 4 | 2017 | 5794 | 0.220 |
Why?
|
| Antidepressive Agents | 2 | 2013 | 2897 | 0.210 |
Why?
|
| Genetic Techniques | 2 | 2008 | 427 | 0.210 |
Why?
|
| Databases, Genetic | 7 | 2016 | 1742 | 0.210 |
Why?
|
| Antipsychotic Agents | 4 | 2016 | 3068 | 0.210 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2022 | 789 | 0.210 |
Why?
|
| Computer Simulation | 14 | 2015 | 6238 | 0.210 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2022 | 3639 | 0.200 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 10 | 2013 | 3704 | 0.200 |
Why?
|
| Homozygote | 8 | 2015 | 1796 | 0.200 |
Why?
|
| Sleep Apnea Syndromes | 3 | 2021 | 975 | 0.200 |
Why?
|
| Informatics | 1 | 2022 | 72 | 0.200 |
Why?
|
| Genetic Testing | 3 | 2014 | 3538 | 0.200 |
Why?
|
| Membrane Glycoproteins | 3 | 2008 | 3702 | 0.190 |
Why?
|
| Autistic Disorder | 3 | 2024 | 1220 | 0.190 |
Why?
|
| Polymorphism, Genetic | 6 | 2017 | 4287 | 0.190 |
Why?
|
| Domestic Violence | 1 | 2003 | 182 | 0.190 |
Why?
|
| Tourette Syndrome | 2 | 2014 | 395 | 0.180 |
Why?
|
| Child of Impaired Parents | 1 | 2004 | 460 | 0.180 |
Why?
|
| Calcium Channels, T-Type | 1 | 2020 | 28 | 0.170 |
Why?
|
| Mental Disorders | 6 | 2016 | 6841 | 0.170 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2023 | 277 | 0.170 |
Why?
|
| Antigens, Neoplasm | 1 | 2008 | 1994 | 0.170 |
Why?
|
| Heme | 1 | 2022 | 313 | 0.170 |
Why?
|
| Adult | 57 | 2024 | 221148 | 0.170 |
Why?
|
| Fragile X Mental Retardation Protein | 3 | 2016 | 116 | 0.170 |
Why?
|
| Clozapine | 3 | 2016 | 506 | 0.170 |
Why?
|
| Interleukin-18 Receptor alpha Subunit | 1 | 2019 | 18 | 0.170 |
Why?
|
| Sequence Deletion | 4 | 2013 | 1494 | 0.170 |
Why?
|
| Triglycerides | 1 | 2007 | 2460 | 0.160 |
Why?
|
| Ferrochelatase | 1 | 2019 | 47 | 0.160 |
Why?
|
| Dementia | 2 | 2023 | 2686 | 0.160 |
Why?
|
| Hexokinase | 1 | 2019 | 125 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 9 | 3 | 2012 | 535 | 0.160 |
Why?
|
| Middle Aged | 48 | 2024 | 220826 | 0.160 |
Why?
|
| Sample Size | 6 | 2020 | 840 | 0.160 |
Why?
|
| Meta-Analysis as Topic | 7 | 2017 | 1377 | 0.160 |
Why?
|
| Osteoporotic Fractures | 1 | 2023 | 411 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 5 | 3 | 2013 | 386 | 0.150 |
Why?
|
| Upper Extremity | 1 | 2023 | 657 | 0.150 |
Why?
|
| Data Interpretation, Statistical | 5 | 2014 | 2691 | 0.150 |
Why?
|
| Amyotrophic Lateral Sclerosis | 4 | 2009 | 1469 | 0.150 |
Why?
|
| Probability | 1 | 2023 | 2478 | 0.150 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2017 | 12143 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 4 | 2 | 2009 | 375 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 16 | 3 | 2014 | 343 | 0.150 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 8 | 2014 | 3779 | 0.140 |
Why?
|
| Child | 24 | 2024 | 80162 | 0.140 |
Why?
|
| Genes | 2 | 2012 | 1844 | 0.140 |
Why?
|
| Atherosclerosis | 3 | 2023 | 3407 | 0.140 |
Why?
|
| Endophenotypes | 2 | 2017 | 255 | 0.140 |
Why?
|
| Risk | 8 | 2019 | 9612 | 0.140 |
Why?
|
| Depression | 7 | 2016 | 8122 | 0.140 |
Why?
|
| Carrier Proteins | 5 | 2015 | 4936 | 0.140 |
Why?
|
| Chromosome Duplication | 2 | 2014 | 75 | 0.140 |
Why?
|
| Gene Deletion | 4 | 2013 | 2667 | 0.140 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2016 | 2898 | 0.140 |
Why?
|
| Logistic Models | 9 | 2015 | 13255 | 0.140 |
Why?
|
| Reproducibility of Results | 9 | 2024 | 20093 | 0.140 |
Why?
|
| Gene Expression Regulation | 7 | 2021 | 11902 | 0.130 |
Why?
|
| Adolescent | 29 | 2023 | 88313 | 0.130 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 2011 | 457 | 0.130 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2016 | 2871 | 0.130 |
Why?
|
| Aged | 29 | 2024 | 169235 | 0.130 |
Why?
|
| Obsessive-Compulsive Disorder | 3 | 2014 | 1491 | 0.130 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 2 | 2007 | 276 | 0.130 |
Why?
|
| Cohort Studies | 20 | 2024 | 41446 | 0.130 |
Why?
|
| DNA Mutational Analysis | 10 | 2016 | 4110 | 0.130 |
Why?
|
| Dendritic Spines | 1 | 2016 | 243 | 0.120 |
Why?
|
| Child, Preschool | 11 | 2024 | 42254 | 0.120 |
Why?
|
| Base Sequence | 7 | 2013 | 12450 | 0.120 |
Why?
|
| Prion Diseases | 1 | 2016 | 100 | 0.120 |
Why?
|
| Major Histocompatibility Complex | 3 | 2012 | 927 | 0.120 |
Why?
|
| Self Report | 7 | 2020 | 3724 | 0.120 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2007 | 502 | 0.120 |
Why?
|
| Myocardial Infarction | 4 | 2023 | 11458 | 0.120 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2014 | 49 | 0.120 |
Why?
|
| Likelihood Functions | 4 | 2015 | 992 | 0.120 |
Why?
|
| Nervous System | 1 | 2017 | 545 | 0.120 |
Why?
|
| DNA, Intergenic | 1 | 2014 | 105 | 0.120 |
Why?
|
| Vesicular Monoamine Transport Proteins | 1 | 2014 | 32 | 0.110 |
Why?
|
| Body Height | 2 | 2010 | 1570 | 0.110 |
Why?
|
| Severity of Illness Index | 8 | 2022 | 15838 | 0.110 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2014 | 894 | 0.110 |
Why?
|
| Penetrance | 1 | 2016 | 388 | 0.110 |
Why?
|
| Carbohydrate Epimerases | 1 | 2013 | 46 | 0.110 |
Why?
|
| Genealogy and Heraldry | 1 | 2013 | 29 | 0.110 |
Why?
|
| Computational Biology | 4 | 2019 | 3517 | 0.110 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2014 | 183 | 0.110 |
Why?
|
| Histocompatibility, Maternal-Fetal | 1 | 2012 | 9 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 2012 | 410 | 0.110 |
Why?
|
| Genes, Recessive | 1 | 2015 | 628 | 0.100 |
Why?
|
| Alpha-Globulins | 1 | 2012 | 26 | 0.100 |
Why?
|
| Fibrillar Collagens | 1 | 2012 | 42 | 0.100 |
Why?
|
| Multiple Sclerosis | 3 | 2015 | 3224 | 0.100 |
Why?
|
| Neurophysiology | 2 | 2024 | 144 | 0.100 |
Why?
|
| Risk Factors | 26 | 2018 | 74167 | 0.100 |
Why?
|
| Mendelian Randomization Analysis | 2 | 2022 | 1008 | 0.100 |
Why?
|
| Loss of Heterozygosity | 2 | 2013 | 662 | 0.100 |
Why?
|
| Arthritis, Rheumatoid | 4 | 2015 | 3755 | 0.100 |
Why?
|
| Blood | 1 | 2014 | 598 | 0.100 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2013 | 187 | 0.100 |
Why?
|
| Suicide, Attempted | 2 | 2011 | 1398 | 0.100 |
Why?
|
| Regression Analysis | 6 | 2018 | 6343 | 0.100 |
Why?
|
| Menorrhagia | 1 | 2012 | 59 | 0.100 |
Why?
|
| Diseases in Twins | 2 | 2007 | 447 | 0.100 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2016 | 682 | 0.100 |
Why?
|
| Finland | 4 | 2017 | 607 | 0.100 |
Why?
|
| Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I | 1 | 2011 | 52 | 0.100 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 2 | 2024 | 322 | 0.090 |
Why?
|
| Lithium Compounds | 2 | 2015 | 223 | 0.090 |
Why?
|
| Hemophilia B | 1 | 2012 | 84 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 3 | 2 | 2010 | 322 | 0.090 |
Why?
|
| Open Reading Frames | 1 | 2014 | 815 | 0.090 |
Why?
|
| Gene Expression | 4 | 2019 | 7584 | 0.090 |
Why?
|
| Personality | 2 | 2008 | 554 | 0.090 |
Why?
|
| Age Factors | 5 | 2020 | 18400 | 0.090 |
Why?
|
| Synaptosomal-Associated Protein 25 | 2 | 2007 | 51 | 0.090 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2012 | 1306 | 0.090 |
Why?
|
| Demography | 2 | 2013 | 1648 | 0.090 |
Why?
|
| Algorithms | 9 | 2015 | 14026 | 0.090 |
Why?
|
| Fasting | 1 | 2017 | 1602 | 0.090 |
Why?
|
| Reference Values | 6 | 2010 | 4921 | 0.090 |
Why?
|
| Psychiatric Status Rating Scales | 6 | 2014 | 6019 | 0.090 |
Why?
|
| Internet | 1 | 2003 | 3092 | 0.090 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2017 | 1496 | 0.090 |
Why?
|
| von Willebrand Diseases | 1 | 2012 | 132 | 0.090 |
Why?
|
| Metabolic Diseases | 1 | 2016 | 681 | 0.090 |
Why?
|
| Calcium Channels | 1 | 2014 | 620 | 0.090 |
Why?
|
| Twins, Dizygotic | 3 | 2007 | 236 | 0.090 |
Why?
|
| Complement C7 | 1 | 2009 | 17 | 0.080 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2019 | 2803 | 0.080 |
Why?
|
| Waist-Hip Ratio | 1 | 2010 | 518 | 0.080 |
Why?
|
| Crohn Disease | 4 | 2013 | 2279 | 0.080 |
Why?
|
| Neurofibromatosis 2 | 2 | 2003 | 385 | 0.080 |
Why?
|
| Aryldialkylphosphatase | 1 | 2009 | 64 | 0.080 |
Why?
|
| Insulin Resistance | 2 | 2017 | 3963 | 0.080 |
Why?
|
| Memory, Short-Term | 1 | 2015 | 982 | 0.080 |
Why?
|
| Twins, Monozygotic | 3 | 2007 | 470 | 0.080 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 2578 | 0.080 |
Why?
|
| Tryptophan | 1 | 2010 | 482 | 0.080 |
Why?
|
| Anxiety Disorders | 3 | 2016 | 2717 | 0.080 |
Why?
|
| Hemophilia A | 1 | 2012 | 360 | 0.080 |
Why?
|
| Membrane Transport Proteins | 2 | 2005 | 1035 | 0.080 |
Why?
|
| Founder Effect | 1 | 2008 | 186 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 2455 | 0.080 |
Why?
|
| Young Adult | 13 | 2019 | 59207 | 0.080 |
Why?
|
| Genomics | 4 | 2016 | 5820 | 0.080 |
Why?
|
| RGS Proteins | 1 | 2008 | 74 | 0.070 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 3 | 2011 | 1988 | 0.070 |
Why?
|
| Autoantigens | 1 | 2012 | 892 | 0.070 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2008 | 57 | 0.070 |
Why?
|
| Clinical Trials as Topic | 1 | 2023 | 8000 | 0.070 |
Why?
|
| Age of Onset | 6 | 2014 | 3304 | 0.070 |
Why?
|
| Anger | 2 | 2007 | 406 | 0.070 |
Why?
|
| Citalopram | 2 | 2008 | 402 | 0.070 |
Why?
|
| Norepinephrine Plasma Membrane Transport Proteins | 1 | 2007 | 66 | 0.070 |
Why?
|
| Genetic Research | 1 | 2008 | 171 | 0.070 |
Why?
|
| Receptors, AMPA | 1 | 2009 | 336 | 0.070 |
Why?
|
| Neurotic Disorders | 2 | 2004 | 77 | 0.070 |
Why?
|
| Language Development Disorders | 2 | 1999 | 193 | 0.070 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2010 | 502 | 0.070 |
Why?
|
| Introns | 2 | 2007 | 981 | 0.070 |
Why?
|
| HLA Antigens | 1 | 2012 | 1371 | 0.070 |
Why?
|
| Receptors, Cannabinoid | 1 | 2006 | 43 | 0.070 |
Why?
|
| Dyslexia | 1 | 2008 | 208 | 0.070 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2007 | 92 | 0.070 |
Why?
|
| Glutamic Acid | 1 | 2012 | 1176 | 0.070 |
Why?
|
| Arginine | 1 | 2010 | 933 | 0.070 |
Why?
|
| Glucokinase | 1 | 2007 | 102 | 0.070 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2007 | 126 | 0.070 |
Why?
|
| Aged, 80 and over | 7 | 2023 | 58956 | 0.070 |
Why?
|
| Multivariate Analysis | 4 | 2013 | 12058 | 0.070 |
Why?
|
| Social Control, Formal | 1 | 2007 | 108 | 0.070 |
Why?
|
| Longitudinal Studies | 3 | 2017 | 14599 | 0.070 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2006 | 61 | 0.070 |
Why?
|
| Lupus Erythematosus, Cutaneous | 1 | 1987 | 73 | 0.070 |
Why?
|
| Chromosomes, Human | 1 | 2008 | 442 | 0.070 |
Why?
|
| Analysis of Variance | 3 | 2011 | 6231 | 0.070 |
Why?
|
| Synaptic Transmission | 1 | 2012 | 1173 | 0.070 |
Why?
|
| Complement Factor H | 1 | 2006 | 110 | 0.070 |
Why?
|
| Selection, Genetic | 2 | 2007 | 869 | 0.070 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2011 | 4510 | 0.070 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2007 | 208 | 0.070 |
Why?
|
| Stress Disorders, Traumatic, Acute | 1 | 2005 | 28 | 0.070 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2007 | 174 | 0.070 |
Why?
|
| DNA | 3 | 2008 | 7219 | 0.060 |
Why?
|
| Parents | 6 | 2012 | 3564 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 4 | 2014 | 5789 | 0.060 |
Why?
|
| Superoxide Dismutase | 1 | 2008 | 594 | 0.060 |
Why?
|
| Cardiovascular Diseases | 2 | 2023 | 15498 | 0.060 |
Why?
|
| Europe | 4 | 2016 | 3423 | 0.060 |
Why?
|
| STAT3 Transcription Factor | 1 | 2010 | 871 | 0.060 |
Why?
|
| Cholesterol, HDL | 1 | 2012 | 1814 | 0.060 |
Why?
|
| Models, Neurological | 1 | 2014 | 1767 | 0.060 |
Why?
|
| Turner Syndrome | 1 | 2006 | 130 | 0.060 |
Why?
|
| Temperament | 1 | 2008 | 297 | 0.060 |
Why?
|
| Schizophrenic Psychology | 2 | 2016 | 1647 | 0.060 |
Why?
|
| Mosaicism | 2 | 2013 | 475 | 0.060 |
Why?
|
| Odds Ratio | 6 | 2017 | 9645 | 0.060 |
Why?
|
| Behavioral Symptoms | 1 | 2007 | 186 | 0.060 |
Why?
|
| Health Surveys | 2 | 2013 | 4059 | 0.060 |
Why?
|
| Hematopoiesis | 1 | 2014 | 2049 | 0.060 |
Why?
|
| Microsatellite Repeats | 4 | 2011 | 785 | 0.060 |
Why?
|
| Gene Duplication | 2 | 2018 | 314 | 0.060 |
Why?
|
| Nerve Net | 2 | 2014 | 2288 | 0.060 |
Why?
|
| DNA Methylation | 1 | 2019 | 4391 | 0.060 |
Why?
|
| Sulpiride | 1 | 2004 | 15 | 0.060 |
Why?
|
| Muscle Proteins | 1 | 2010 | 1154 | 0.060 |
Why?
|
| Hydrolases | 1 | 2005 | 147 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 15 | 3 | 2013 | 361 | 0.060 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2014 | 2824 | 0.060 |
Why?
|
| Chromosomes, Mammalian | 1 | 2005 | 147 | 0.060 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2010 | 1135 | 0.060 |
Why?
|
| Cell Cycle Proteins | 1 | 2016 | 3447 | 0.060 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2005 | 194 | 0.060 |
Why?
|
| Dreams | 1 | 1986 | 146 | 0.060 |
Why?
|
| Models, Theoretical | 2 | 2015 | 3576 | 0.060 |
Why?
|
| RNA | 2 | 2013 | 2723 | 0.060 |
Why?
|
| Neuregulin-1 | 1 | 2005 | 135 | 0.060 |
Why?
|
| Chi-Square Distribution | 4 | 2006 | 3418 | 0.060 |
Why?
|
| Brain Chemistry | 1 | 2008 | 959 | 0.060 |
Why?
|
| Neoplasm Proteins | 2 | 2016 | 3612 | 0.060 |
Why?
|
| Sampling Studies | 2 | 2003 | 615 | 0.060 |
Why?
|
| Sex Characteristics | 3 | 2020 | 2637 | 0.060 |
Why?
|
| Disease Susceptibility | 2 | 2009 | 1793 | 0.060 |
Why?
|
| Antisocial Personality Disorder | 1 | 2005 | 224 | 0.060 |
Why?
|
| Mood Disorders | 1 | 2010 | 1127 | 0.060 |
Why?
|
| Developmental Disabilities | 1 | 2012 | 1509 | 0.060 |
Why?
|
| Circadian Rhythm | 1 | 2015 | 2574 | 0.060 |
Why?
|
| Matched-Pair Analysis | 2 | 2001 | 283 | 0.060 |
Why?
|
| Dissociative Disorders | 1 | 2005 | 234 | 0.050 |
Why?
|
| Chromosome Breakpoints | 2 | 2014 | 93 | 0.050 |
Why?
|
| Affective Disorders, Psychotic | 1 | 2004 | 186 | 0.050 |
Why?
|
| Clinical Protocols | 1 | 2009 | 1440 | 0.050 |
Why?
|
| Molecular Sequence Data | 4 | 2014 | 17644 | 0.050 |
Why?
|
| Anxiety | 4 | 2016 | 4572 | 0.050 |
Why?
|
| Huntington Disease | 1 | 2010 | 1144 | 0.050 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2011 | 1931 | 0.050 |
Why?
|
| Neural Pathways | 1 | 2014 | 3057 | 0.050 |
Why?
|
| Trans-Activators | 2 | 2007 | 2856 | 0.050 |
Why?
|
| Violence | 1 | 2009 | 937 | 0.050 |
Why?
|
| Germany | 3 | 2011 | 875 | 0.050 |
Why?
|
| Chromatin | 1 | 2014 | 2960 | 0.050 |
Why?
|
| Hematologic Neoplasms | 1 | 2014 | 1896 | 0.050 |
Why?
|
| Secondary Prevention | 1 | 2009 | 1474 | 0.050 |
Why?
|
| Antigens, Differentiation | 1 | 2005 | 910 | 0.050 |
Why?
|
| Marijuana Abuse | 1 | 2006 | 411 | 0.050 |
Why?
|
| Sex Factors | 6 | 2019 | 10548 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 2017 | 277 | 0.050 |
Why?
|
| Social Behavior | 3 | 2016 | 1134 | 0.050 |
Why?
|
| Neuropsychological Tests | 4 | 2017 | 7045 | 0.050 |
Why?
|
| Family Health | 3 | 2012 | 1257 | 0.050 |
Why?
|
| Lod Score | 3 | 2013 | 602 | 0.050 |
Why?
|
| Insulin | 1 | 2017 | 6602 | 0.050 |
Why?
|
| Sequence Alignment | 1 | 2006 | 2179 | 0.050 |
Why?
|
| Genes, Neurofibromatosis 2 | 1 | 2002 | 122 | 0.050 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2014 | 3396 | 0.050 |
Why?
|
| Parent-Child Relations | 1 | 2007 | 761 | 0.050 |
Why?
|
| Siblings | 4 | 2008 | 825 | 0.050 |
Why?
|
| Software Design | 1 | 2002 | 171 | 0.050 |
Why?
|
| Statistics, Nonparametric | 3 | 2017 | 2851 | 0.050 |
Why?
|
| Drug Resistance | 1 | 2008 | 1595 | 0.050 |
Why?
|
| Aging | 1 | 2020 | 8705 | 0.050 |
Why?
|
| Stroke | 1 | 2023 | 9756 | 0.050 |
Why?
|
| Sibling Relations | 1 | 2001 | 46 | 0.050 |
Why?
|
| Scotland | 2 | 2013 | 143 | 0.050 |
Why?
|
| Receptors, GABA-A | 1 | 2005 | 623 | 0.050 |
Why?
|
| Genetic Heterogeneity | 2 | 2016 | 732 | 0.050 |
Why?
|
| London | 2 | 2011 | 234 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2012 | 3612 | 0.050 |
Why?
|
| Molecular Chaperones | 1 | 2005 | 755 | 0.050 |
Why?
|
| Caveolin 1 | 1 | 2022 | 256 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 8596 | 0.050 |
Why?
|
| Alcoholism | 1 | 2011 | 1973 | 0.050 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 7595 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 22 | 2 | 2013 | 346 | 0.040 |
Why?
|
| Statistics as Topic | 1 | 2006 | 2358 | 0.040 |
Why?
|
| Proteins | 1 | 2015 | 6032 | 0.040 |
Why?
|
| Signal Transduction | 6 | 2021 | 23441 | 0.040 |
Why?
|
| Smoking | 2 | 2007 | 9052 | 0.040 |
Why?
|
| Educational Measurement | 1 | 2007 | 1254 | 0.040 |
Why?
|
| Blood Volume | 1 | 2001 | 548 | 0.040 |
Why?
|
| Self Concept | 1 | 1986 | 1043 | 0.040 |
Why?
|
| Body Weight | 1 | 2010 | 4618 | 0.040 |
Why?
|
| Work Schedule Tolerance | 1 | 2024 | 551 | 0.040 |
Why?
|
| Ireland | 2 | 2010 | 171 | 0.040 |
Why?
|
| Cadherins | 2 | 2011 | 904 | 0.040 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2002 | 485 | 0.040 |
Why?
|
| Dystrophin-Associated Proteins | 2 | 2010 | 59 | 0.040 |
Why?
|
| Oxygen | 2 | 2022 | 4228 | 0.040 |
Why?
|
| Databases, Factual | 3 | 2024 | 7956 | 0.040 |
Why?
|
| Quality Control | 2 | 2012 | 832 | 0.040 |
Why?
|
| Macular Degeneration | 1 | 2006 | 1007 | 0.040 |
Why?
|
| Alternative Splicing | 2 | 2015 | 1093 | 0.040 |
Why?
|
| Research Design | 2 | 2024 | 6178 | 0.040 |
Why?
|
| Autoantibodies | 1 | 1987 | 2124 | 0.040 |
Why?
|
| Prospective Studies | 6 | 2023 | 54415 | 0.040 |
Why?
|
| Psychomotor Disorders | 1 | 1999 | 149 | 0.040 |
Why?
|
| Prevalence | 3 | 2019 | 15717 | 0.040 |
Why?
|
| Neuroma, Acoustic | 1 | 2002 | 459 | 0.040 |
Why?
|
| Personality Inventory | 3 | 2007 | 1019 | 0.040 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2016 | 411 | 0.040 |
Why?
|
| Fear | 1 | 2006 | 1476 | 0.040 |
Why?
|
| Child Behavior Disorders | 1 | 2002 | 804 | 0.040 |
Why?
|
| Fatigue | 1 | 2005 | 1551 | 0.040 |
Why?
|
| Homeodomain Proteins | 1 | 2007 | 2416 | 0.040 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2019 | 263 | 0.040 |
Why?
|
| Interpersonal Relations | 1 | 2005 | 1436 | 0.040 |
Why?
|
| Glutamate Plasma Membrane Transport Proteins | 1 | 2016 | 11 | 0.040 |
Why?
|
| Acid Anhydride Hydrolases | 1 | 2016 | 67 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2014 | 7856 | 0.030 |
Why?
|
| Receptor, Serotonin, 5-HT1B | 2 | 2007 | 36 | 0.030 |
Why?
|
| Canada | 1 | 2022 | 2120 | 0.030 |
Why?
|
| Neuronal Plasticity | 2 | 2016 | 1435 | 0.030 |
Why?
|
| Aminopeptidases | 1 | 2017 | 95 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2017 | 421 | 0.030 |
Why?
|
| Cross-Sectional Studies | 3 | 2024 | 26112 | 0.030 |
Why?
|
| X Chromosome Inactivation | 1 | 2018 | 227 | 0.030 |
Why?
|
| Suicide | 1 | 2007 | 1598 | 0.030 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2003 | 1351 | 0.030 |
Why?
|
| Recombination, Genetic | 2 | 2013 | 1525 | 0.030 |
Why?
|
| Information Dissemination | 1 | 2024 | 1126 | 0.030 |
Why?
|
| Comorbidity | 4 | 2014 | 10498 | 0.030 |
Why?
|
| Patient Selection | 1 | 2008 | 4244 | 0.030 |
Why?
|
| Portugal | 2 | 2005 | 91 | 0.030 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2017 | 233 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2011 | 3812 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2017 | 36423 | 0.030 |
Why?
|
| Systems Biology | 1 | 2019 | 481 | 0.030 |
Why?
|
| Xenopus laevis | 2 | 1996 | 963 | 0.030 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2015 | 161 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2019 | 829 | 0.030 |
Why?
|
| beta Catenin | 2 | 2016 | 1040 | 0.030 |
Why?
|
| United States | 6 | 2024 | 72339 | 0.030 |
Why?
|
| Genetic Code | 1 | 2014 | 138 | 0.030 |
Why?
|
| Prions | 1 | 2016 | 180 | 0.030 |
Why?
|
| Pyramidal Cells | 1 | 2016 | 369 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 2007 | 4027 | 0.030 |
Why?
|
| Ubiquitin | 1 | 2019 | 839 | 0.030 |
Why?
|
| Serine Endopeptidases | 1 | 2019 | 1021 | 0.030 |
Why?
|
| Child Abuse | 1 | 2003 | 1075 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2020 | 1567 | 0.030 |
Why?
|
| Internationality | 2 | 2010 | 1001 | 0.030 |
Why?
|
| Education | 1 | 2016 | 536 | 0.030 |
Why?
|
| Minisatellite Repeats | 2 | 2005 | 164 | 0.030 |
Why?
|
| Iron | 1 | 2022 | 1792 | 0.030 |
Why?
|
| Mass Screening | 1 | 2009 | 5428 | 0.030 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 2 | 2007 | 415 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2016 | 934 | 0.030 |
Why?
|
| Research | 1 | 2021 | 1977 | 0.030 |
Why?
|
| Wounds and Injuries | 1 | 2005 | 2491 | 0.030 |
Why?
|
| Michigan | 1 | 2013 | 339 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2022 | 4124 | 0.030 |
Why?
|
| Methylation | 1 | 2015 | 1083 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2010 | 12951 | 0.030 |
Why?
|
| Gene Order | 1 | 2012 | 169 | 0.030 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2016 | 568 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2007 | 6391 | 0.030 |
Why?
|
| Lithium | 1 | 2015 | 596 | 0.030 |
Why?
|
| Task Performance and Analysis | 1 | 2016 | 761 | 0.030 |
Why?
|
| Chromosome Segregation | 1 | 2013 | 235 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2014 | 522 | 0.030 |
Why?
|
| Bulgaria | 1 | 2011 | 17 | 0.030 |
Why?
|
| Post-Synaptic Density | 1 | 2011 | 11 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2013 | 310 | 0.020 |
Why?
|
| AIDS-Related Complex | 1 | 2011 | 107 | 0.020 |
Why?
|
| Marital Status | 1 | 2013 | 426 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2020 | 2769 | 0.020 |
Why?
|
| Antimanic Agents | 1 | 2015 | 520 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2012 | 313 | 0.020 |
Why?
|
| Health Status | 1 | 2005 | 4075 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2017 | 14409 | 0.020 |
Why?
|
| Iceland | 1 | 2011 | 184 | 0.020 |
Why?
|
| Trisomy | 1 | 2013 | 260 | 0.020 |
Why?
|
| Animals | 10 | 2020 | 168441 | 0.020 |
Why?
|
| Genetics, Medical | 1 | 2014 | 336 | 0.020 |
Why?
|
| Heart Rate | 1 | 2023 | 4198 | 0.020 |
Why?
|
| Socioeconomic Factors | 3 | 2013 | 7825 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2016 | 1246 | 0.020 |
Why?
|
| Germ-Line Mutation | 2 | 2014 | 1858 | 0.020 |
Why?
|
| Africa | 1 | 2013 | 710 | 0.020 |
Why?
|
| Clone Cells | 1 | 2014 | 1659 | 0.020 |
Why?
|
| PubMed | 1 | 2011 | 129 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2001 | 2727 | 0.020 |
Why?
|
| Time Factors | 2 | 2023 | 39975 | 0.020 |
Why?
|
| Rare Diseases | 1 | 2016 | 621 | 0.020 |
Why?
|
| Lysine | 1 | 2015 | 992 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2010 | 6395 | 0.020 |
Why?
|
| Adrenomedullin | 1 | 2010 | 85 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2017 | 14664 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 1743 | 0.020 |
Why?
|
| Lactase | 1 | 2010 | 71 | 0.020 |
Why?
|
| Interviews as Topic | 2 | 2008 | 2696 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2014 | 633 | 0.020 |
Why?
|
| Lipase | 1 | 2012 | 325 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 6086 | 0.020 |
Why?
|
| Zebrafish Proteins | 1 | 1996 | 1014 | 0.020 |
Why?
|
| Base Pairing | 1 | 2010 | 140 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2014 | 1967 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2014 | 1791 | 0.020 |
Why?
|
| Histone Chaperones | 1 | 2010 | 83 | 0.020 |
Why?
|
| Selection Bias | 1 | 2011 | 359 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2017 | 2328 | 0.020 |
Why?
|
| Pennsylvania | 1 | 2010 | 613 | 0.020 |
Why?
|
| Confidentiality | 1 | 2013 | 609 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2016 | 1667 | 0.020 |
Why?
|
| Jews | 1 | 2010 | 364 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2011 | 749 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2024 | 3429 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2015 | 1509 | 0.020 |
Why?
|
| Quebec | 1 | 2008 | 141 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2009 | 350 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 2013 | 1125 | 0.020 |
Why?
|
| Vocabulary | 2 | 1999 | 165 | 0.020 |
Why?
|
| Edar Receptor | 1 | 2007 | 24 | 0.020 |
Why?
|
| Immunodiffusion | 1 | 1987 | 149 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2010 | 783 | 0.020 |
Why?
|
| Histone Acetyltransferases | 1 | 2010 | 336 | 0.020 |
Why?
|
| Receptors, Dopamine D5 | 1 | 2007 | 32 | 0.020 |
Why?
|
| Sp1 Transcription Factor | 1 | 2008 | 140 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2014 | 1363 | 0.020 |
Why?
|
| Pteroylpolyglutamic Acids | 1 | 2007 | 9 | 0.020 |
Why?
|
| Sialyltransferases | 1 | 2008 | 83 | 0.020 |
Why?
|
| Body Size | 1 | 2010 | 463 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2012 | 1699 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2011 | 616 | 0.020 |
Why?
|
| Japan | 1 | 2011 | 1371 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2016 | 2448 | 0.020 |
Why?
|
| China | 1 | 2013 | 2366 | 0.020 |
Why?
|
| Social Alienation | 1 | 2006 | 19 | 0.020 |
Why?
|
| Individuality | 2 | 1999 | 300 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2015 | 9418 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2013 | 39117 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2008 | 430 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2016 | 4278 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 2012 | 1393 | 0.020 |
Why?
|
| Vietnam Conflict | 1 | 2007 | 100 | 0.020 |
Why?
|
| Adiposity | 1 | 2016 | 1877 | 0.020 |
Why?
|
| Colorado | 1 | 2006 | 165 | 0.020 |
Why?
|
| Mental Processes | 1 | 2008 | 244 | 0.020 |
Why?
|
| Rodentia | 1 | 2008 | 262 | 0.020 |
Why?
|
| Proteome | 1 | 2016 | 1862 | 0.020 |
Why?
|
| Antiporters | 1 | 2007 | 278 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2008 | 638 | 0.020 |
Why?
|
| Sugar Acids | 1 | 1985 | 24 | 0.020 |
Why?
|
| Infant | 2 | 2024 | 36205 | 0.020 |
Why?
|
| Lipid A | 1 | 1985 | 70 | 0.020 |
Why?
|
| International Cooperation | 1 | 2012 | 1422 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 2012 | 1420 | 0.020 |
Why?
|
| Educational Status | 1 | 2013 | 2520 | 0.020 |
Why?
|
| Receptor, Serotonin, 5-HT1D | 1 | 2005 | 9 | 0.020 |
Why?
|
| Verbal Behavior | 1 | 2007 | 335 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | 2005 | 64 | 0.020 |
Why?
|
| Israel | 1 | 2008 | 726 | 0.020 |
Why?
|
| Receptor, Serotonin, 5-HT2C | 1 | 2005 | 42 | 0.020 |
Why?
|
| Data Mining | 1 | 2010 | 551 | 0.020 |
Why?
|
| Geography | 1 | 2007 | 656 | 0.020 |
Why?
|
| Neural Stem Cells | 1 | 2012 | 888 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2011 | 909 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2012 | 2706 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2014 | 2571 | 0.020 |
Why?
|
| DNA Primers | 2 | 2003 | 2820 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2016 | 8320 | 0.020 |
Why?
|
| Histones | 1 | 2015 | 2580 | 0.020 |
Why?
|
| Neurons | 2 | 2016 | 9462 | 0.020 |
Why?
|
| Glycolipids | 1 | 1985 | 206 | 0.020 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2005 | 94 | 0.020 |
Why?
|
| Combat Disorders | 1 | 2007 | 301 | 0.020 |
Why?
|
| Fetus | 1 | 2012 | 1864 | 0.020 |
Why?
|
| Markov Chains | 1 | 2008 | 966 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2011 | 3087 | 0.020 |
Why?
|
| Monoamine Oxidase | 1 | 2005 | 181 | 0.010 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2004 | 109 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2012 | 2611 | 0.010 |
Why?
|
| Verbal Learning | 1 | 2007 | 463 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 2005 | 750 | 0.010 |
Why?
|
| Homocysteine | 1 | 2007 | 638 | 0.010 |
Why?
|
| Proteomics | 1 | 2017 | 3845 | 0.010 |
Why?
|
| Mice | 3 | 2020 | 81509 | 0.010 |
Why?
|
| Hippocampus | 1 | 2016 | 3763 | 0.010 |
Why?
|
| Symporters | 1 | 2006 | 363 | 0.010 |
Why?
|
| Salmonella typhimurium | 1 | 1985 | 347 | 0.010 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2007 | 602 | 0.010 |
Why?
|
| Review Literature as Topic | 1 | 2005 | 347 | 0.010 |
Why?
|
| Menopause | 1 | 2011 | 1646 | 0.010 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2005 | 324 | 0.010 |
Why?
|
| Multigene Family | 1 | 2006 | 1077 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1987 | 2469 | 0.010 |
Why?
|
| Pharmacogenetics | 1 | 2007 | 675 | 0.010 |
Why?
|
| South Africa | 1 | 2008 | 1841 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 13449 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 2012 | 2382 | 0.010 |
Why?
|
| Protein Binding | 1 | 2014 | 9352 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2002 | 330 | 0.010 |
Why?
|
| Gene Pool | 1 | 2001 | 36 | 0.010 |
Why?
|
| North America | 1 | 2005 | 1276 | 0.010 |
Why?
|
| Taiwan | 1 | 2003 | 516 | 0.010 |
Why?
|
| Crime Victims | 1 | 2005 | 347 | 0.010 |
Why?
|
| Peer Group | 1 | 2007 | 692 | 0.010 |
Why?
|
| Receptors, Dopamine D4 | 1 | 2002 | 170 | 0.010 |
Why?
|
| Ohio | 1 | 2001 | 322 | 0.010 |
Why?
|
| Parenting | 1 | 2007 | 699 | 0.010 |
Why?
|
| Models, Psychological | 1 | 2005 | 828 | 0.010 |
Why?
|
| Retrospective Studies | 3 | 2020 | 80582 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 3792 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2017 | 8999 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2004 | 1755 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1987 | 3810 | 0.010 |
Why?
|
| Obstetric Labor Complications | 1 | 2002 | 236 | 0.010 |
Why?
|
| Consciousness | 1 | 1986 | 601 | 0.010 |
Why?
|
| Accidents, Traffic | 1 | 2005 | 816 | 0.010 |
Why?
|
| Registries | 1 | 2016 | 8223 | 0.010 |
Why?
|
| Recurrence | 1 | 2012 | 8469 | 0.010 |
Why?
|
| Stem Cells | 1 | 2012 | 3522 | 0.010 |
Why?
|
| Affect | 1 | 2007 | 1485 | 0.010 |
Why?
|
| Impulsive Behavior | 1 | 2002 | 346 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2014 | 12796 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2010 | 3312 | 0.010 |
Why?
|
| Adolescent Behavior | 1 | 2007 | 1186 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2006 | 1887 | 0.010 |
Why?
|
| Factor Analysis, Statistical | 1 | 2000 | 999 | 0.010 |
Why?
|
| Infant, Low Birth Weight | 1 | 2002 | 869 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2007 | 5439 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 2002 | 1745 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2012 | 18964 | 0.010 |
Why?
|
| Wnt1 Protein | 1 | 1996 | 120 | 0.010 |
Why?
|
| Emotions | 1 | 2008 | 2739 | 0.010 |
Why?
|
| Protein Sorting Signals | 1 | 1996 | 279 | 0.010 |
Why?
|
| Microinjections | 1 | 1996 | 321 | 0.010 |
Why?
|
| Cytokines | 1 | 2010 | 7392 | 0.010 |
Why?
|
| Models, Biological | 1 | 2011 | 9469 | 0.010 |
Why?
|
| RNA Caps | 1 | 1995 | 73 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2005 | 4001 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1996 | 489 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 2011 | 4420 | 0.010 |
Why?
|
| Prognosis | 1 | 2015 | 29620 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2004 | 6309 | 0.010 |
Why?
|
| Gestational Age | 1 | 2002 | 3576 | 0.010 |
Why?
|
| Xenopus Proteins | 1 | 1996 | 434 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2010 | 10203 | 0.010 |
Why?
|
| Veterans | 1 | 2007 | 2647 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1996 | 1900 | 0.010 |
Why?
|
| Wnt Proteins | 1 | 1996 | 718 | 0.010 |
Why?
|
| Embryo, Nonmammalian | 1 | 1995 | 906 | 0.010 |
Why?
|
| Residence Characteristics | 1 | 2001 | 2092 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2010 | 12125 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2000 | 2597 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 64651 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2010 | 23990 | 0.000 |
Why?
|
| Pregnancy Complications | 1 | 2002 | 2947 | 0.000 |
Why?
|
| Obesity | 1 | 2010 | 12938 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 2005 | 22163 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2003 | 15262 | 0.000 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1995 | 3734 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1996 | 11073 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 2002 | 26212 | 0.000 |
Why?
|
| Species Specificity | 1 | 1985 | 2416 | 0.000 |
Why?
|
| Pregnancy | 1 | 2002 | 29862 | 0.000 |
Why?
|
| Temperature | 1 | 1985 | 2228 | 0.000 |
Why?
|
| Mass Spectrometry | 1 | 1985 | 2192 | 0.000 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1985 | 3769 | 0.000 |
Why?
|
| Lipids | 1 | 1985 | 3340 | 0.000 |
Why?
|